CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 14 enrolled
Drug / intervention
Ropivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02950558
NCT02950558Phase 4Completed

Pilot Study: Extended Regional Anesthesia to Prevent Chronic Pain After Ankle Fracture Surgery

University of Cincinnati·interventional·Posted Nov 1, 2016·Updated Jul 2, 2021

In Brief

A Phase 4 clinical trial evaluating Ropivacaine and Nerve block for Chronic Pain and 2 related conditions. Completed, enrolled 14 participants across 2 sites.

Detailed Summary

This pilot study will test the hypothesis that prolonged regional peripheral nerve block will reduce development of chronic pain in patients undergoing surgery for ankle fracture compared to standard of care. Subjects will be followed for one year.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 1, 2016
Enrollment StartMay 29, 2018
Primary CompletionNov 14, 2019
Study CompletionJun 19, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.7 years ago

Interventions

Ropivacainedrug

Single injection of ropivacaine immediately prior to surgery.

Nerve blockprocedure

insertion of catheter to deliver continuous 5 day popliteal sciatic nerve block using a disposable ambulatory pain pump.